Renaissance Group »

Jazz Pharmaceuticals shares owned by Renaissance Group

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by Renaissance Group from 13F filings

Historical chart of Renaissance Group investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by Renaissance Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by Renaissance Group

Quarter filed Position value Share count Share price at filing
2012-09-30 $205k 3.6k 56.93

More positions owned by Renaissance Group

Apple (AAPL)
Microsoft Corporation (MSFT)
Ptc (PTC)
Broadcom (AVGO)
salesforce (CRM)
Servicenow (NOW)
Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Amphenol Corporation (APH)
Vertex Pharmaceuticals Incorporated (VRTX)
Applied Materials (AMAT)
Facebook Inc cl a (META)
Cdw (CDW)
Cintas Corporation (CTAS)
Ferguson Plc F (FERG)

View all positions for Renaissance Group

Top funds holding Jazz Pharmaceuticals

Vanguard Group
LSV Asset Management
Jpmorgan Chase & Co
Wellington Management Company
Polaris Capital Management
Pacer Advisors
EcoR1 Capital
Franklin Resources
Dimensional Fund Advisors
Bnp Paribas Investment Partners
Samlyn Capital
Millennium Management
Bank of New York Mellon
Charles Schwab Investment Management
Avidity Partners Management

View all funds holding Jazz Pharmaceuticals